Friday, April 3, 2015

Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes.

 2015 Apr;72(4):712-716. doi: 10.1016/j.jaad.2014.10.012. Epub 2015 Jan 16.

Promising alternative clinical uses of prostaglandin F2α analogs: Beyond the eyelashes.

Abstract

Prostaglandin F2α analogs, commonly prescribed for glaucoma treatment, have been shown to induce side effects such as cutaneous hypertrichosis and hyperpigmentation. Therefore, these medications have theoretic applications in the treatment of alopecia and disorders of hypopigmentation. We reviewed the literature to find original studies assessing the use of prostaglandin F2α analogs in these settings. Studies and reports were analyzed in regards to androgenic alopeciaalopecia areata, chemotherapy-induced alopecia, vitiligo, and hypopigmented scarring. Based on the results of these studies, and consideration of pathophysiologic mechanism, the most promising applications for prostaglandin F2α analogs include androgenicalopecia, chemotherapy-induced alopecia, and alopecia areata concurrently treated with corticosteroids.
Copyright © 2014 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

alopecia areata; androgenic alopecia; bimatoprost; glaucoma; latanoprost; prostaglandin; prostaglandin F2α analog; travoprost; vitiligo

No comments:

Post a Comment